Aimei Health SPAC extends deadline to March 6, 2025; shareholders redeem 2.9M shares for $31.3M

Aimei Health Technology Co., Ltd.

Shareholders approved amendments to allow monthly extensions at $150,000 for all public shares (down from per-share amounts).
$150,000 promissory note issued to sponsors Aimei Investment Ltd and United Hydrogen to fund the first extension.
Holders of 2,904,267 public shares redeemed at ~$10.77 per share, aggregating ~$31.27 million from trust.
Trust account balance post-redemptions is ~$43.02 million with 6,121,733 shares outstanding.
Extension deposited on Feb 3, 2025 extends business combination deadline from Feb 6, 2025 to March 6, 2025.

item 1.01 item 2.03 item 3.03 item 5.07 item 5.03 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.